Pharmacogenomics: Convergence of Pharmacology & Genomics
Personalized medicine can be used to learn about a person's genetic makeup and to unravel the biology of their tumor. Using this information, doctors hope to identify prevention, screening, and treatment strategies that may be more effective and cause fewer side effects than would be expected with standard treatments. By performing more genetic tests and analysis, doctors may customize treatment to each patient's needs. Creating a personalized cancer screening and treatment plan includes: Determining the chances that a person will develop cancer and selecting screening strategies to lower the risk, Matching patients with treatments that are more likely to be effective and cause fewer side effects, Predicting the risk of recurrence (return of cancer)
- Predictive computational phenotyping
- New era of Proteomics
- Drug metabolizing enzymes
- Protein microarrays for personalized medicine
- Genotyping & genome sequencing
Related Conference of Pharmacogenomics: Convergence of Pharmacology & Genomics
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
18th International Conference on Human Genomics and Genomic Medicine
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Modern Phenotypic Drug Discovery Defining the Path Forward D1
G Protein-Coupled Receptors Structure Signaling and Drug Discovery B3
Molecular Medicine Tri-Conference 2016
Cancer Center Business Summit 2016
Molecular Diagnostics World Summit MolrDIAx 2016
27th Annual Cancer Progress Conference 2016
Personalized Diagnostics 2016
Biobanking 2016
GTCbio s Novel Immunotherapeutics Summit 2016
6th ANNUAL PHARMACOVIGILANCE AND RISK MANAGEMENT STRATEGIES FORUM
African Pharmac 2016eutical Summit
11th Annual Biomarkers Congress 2016
Biomarkers Summit 2016
10th Personalized Medicine World Congress 2016
International Congress on Personalized Health Care
Modern Phenotypic Drug Discovery Defining the Path Forward D1
G Protein-Coupled Receptors Structure Signaling and Drug Discovery B3
Molecular Medicine Tri-Conference 2016
Cancer Center Business Summit 2016
Molecular Diagnostics World Summit MolrDIAx 2016
27th Annual Cancer Progress Conference 2016
Personalized Diagnostics 2016
Biobanking 2016
GTCbio s Novel Immunotherapeutics Summit 2016
6th ANNUAL PHARMACOVIGILANCE AND RISK MANAGEMENT STRATEGIES FORUM
African Pharmac 2016eutical Summit
11th Annual Biomarkers Congress 2016
Biomarkers Summit 2016
10th Personalized Medicine World Congress 2016
International Congress on Personalized Health Care
Pharmacogenomics: Convergence of Pharmacology & Genomics Conference Speakers
Recommended Sessions
- Advances In Molecular Diagnostics
- Approaches To Stem Cells
- Cardiology and vascular medicine
- Clinical Case Reports
- Genetics Of Ebola Outbreak
- Genomics & Personalized Medicine
- Immunology infectious disease
- Lifestyle Medicine
- Market Strategies & Challenges In Personalised Medicine
- Nanotechnology: Future Of Personalised Medicine
- Paths Of Biomarkers
- Personalised Medicine In 21st Century
- Personalized Drug Therapy
- Personalized Medicine & its Innovations
- Personalized oncology
- Pharmacogenomics: Convergence of Pharmacology & Genomics
- Preventive Medicines
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)